AIAISci
中文
clinical updateBiotech

Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

Clinical/translation signal: Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

Occurred SourceClinicalTrials.govapprovedSourceClinicalTrials.gov

Factual summary

What happened

ClinicalTrials.gov registry update for Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

SourceClinicalTrials.gov

Why it matters

Clinical trial registry updates are translation signals, not commercialization claims by themselves.

SourceClinicalTrials.gov

Limitations

ClinicalTrials.gov status does not prove product approval, licensing, revenue, or market adoption.

SourceClinicalTrials.gov

Linked output

Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancerclinical trial

People

No reviewed person relationship is attached to this event.

Organizations

National Cancer Institute (NCI)

Topics

No reviewed topic relationship is attached to this event.

Problems

No reviewed problem relationship is attached to this event.

Relationship evidence

Timeline

  1. clinical updateProstate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer
    SourceClinicalTrials.gov